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Abstract 
Isothermal microcalorimetry (IMC) is particularly suited to the study of microbiological 
samples in complex or heterogeneous environments because it does not require optical 
clarity of the sample and can detect metabolic activity from as few as 104 CFU/mL cells. 
While the use of IMC for studying planktonic cultures is well established, in the clinical 
environment bacteria are most likely to be present as biofilms. Biofilm prevention and 
eradication present a number of challenges to designers and users of medical devices and 
implants, since bacteria in biofilm colonies are usually more resistant to antimicrobial agents. 
Analytical tools that facilitate investigation of biofilm formation are therefore extremely useful. 
While it is possible to study pre-prepared biofilms in closed ampoules, better correlation with 
in-vivo behaviour can be achieved using a system in which the bacterial suspension is 
flowing. Here, we discuss the potential of flow calorimetry for studying biofilms and report the 
development of a simple flow system that can be housed in a microcalorimeter. The use of 
the flow system is demonstrated with biofilms of Staphylococcus aureus. 
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1. Introduction 
Isothermal microcalorimetry (IMC) is a technique that permits accurate measurement of 
extremely small powers (<1 µW) and which imposes no requirements on the physical nature 
of the sample under investigation (the sample can be solid, liquid or inhomogeneous for 
instance). These qualities make it ideally suited to the study of bacterial growth and 
metabolism in real-time. In particular, the exquisite sensitivity means as few as 104 
metabolically active cells can be detected [1]. Further, it is possible to monitor bacterial 
activity in the presence of antimicrobial agents and/or medical devices and implants because 
there is no requirement for optical clarity of the test system. 
 
IMC has been used to follow microbiological activity in a wide range of applications, 
including for monitoring and quantifying soil microbial activity and contamination [2-3], 
treatment of sewage [4], detecting infection in and contamination of clinical products and 
samples [5], quantifying the efficacy of antimicrobial compounds [6-7], including the mode of 
action of bacteriostatic or bactericidal compounds [8] and antiviral compounds [9-10] and 
looking at spoilage of food [11]. A few studies have been conducted on defined mixed 
cultures with the aim of investigating the relationship between two or more bacteria (for 
instance, [12-14]). 
 
An area of particular clinical interest is in monitoring attachment and colonisation of bacteria 
to form biofilms on the surface of medical implants and devices. Indwelling medical devices 
are crucial components of modern healthcare practice. For example, at any one time up to 
10% of patients in a hospital may have an indwelling catheter [15]. However, these devices 
create a pathway into the warm, nutrient rich environment inside a patient that is usually 
inaccessible to bacteria, thus acting as a conduit between the patient and the non-sterile 
outside environment [16-17].  Microorganisms may also irreversibly adhere to the surfaces of 
medical devices, forming biofilms [18]. Biofilms are sessile communities of microorganisms 
typically held together by an extracellular matrix [19]. Studies using Pseudomonas 
aeruginosa have shown that biofilm development proceeds in stages including initial 
attachment, production of extrapolymeric substances (EPS), early development of biofilm 
architecture, maturation of biofilm architecture and finally release of cells from the mature 
biofilm [20-21]. The presence of biofilms in medical devices poses a threat to patients as a 
result of the inherent resistance to antimicrobials [22]. Biofilms may also act as a starting 
point for further infection as cells are released or sloughed off the biofilm [23]. Urinary tract 
infections are the most common hospital acquired infections [24] and the length of time that 
catheters are used influences the likelihood of infection. For example catheterisation for 
more than four weeks results in urinary tract infections in almost all cases [15]. However, 
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even brief catheterisation, of less than ten days, resulted in 26% of patients contracting 
urinary tract infections [25].  
 
1.1. In vitro medical device testing 
Since in vivo determination of biofilm formation and activity is difficult, analytical methods are 
required to understand in vitro how biofilms form on medical devices and to determine how 
effective antibiofilm technologies or eradication measures may be [17]. Biofilms can be 
difficult to generate in vitro, because the drivers that direct bacteria to form biofilms are not 
always clear, but environmental stresses, including shear forces, are known to play a role. 
Biofilms are usually created in microbial bioreactors, typically of one of three designs; closed 
batch systems with limited substrate, continuous flow stirred tank reactors (CFSTR) and plug 
flow reactors (PFR) [26]. With batch systems, the substrate concentration declines while 
there is a concomitant increase in biomass. With a CFSTR system, the quantities of 
substrate and biological products remain constant because a continuous flow of fresh 
substrate is introduced at the same rate as accumulating metabolic by-products are removed 
[26]. A PFR system is ‘fed’ initially and there is continuous flow to a waste vessel but 
conditions are otherwise similar to batch systems with accumulated biomass and reduced 
substrate over the course of experiments [26].  
 
Irrespective of their basic design, flow models typically rely on shear forces to drive biofilm 
formation and utilise plastic inserts (or coupons) that act as a surface to initiate and support 
biofilm growth. The coupons are removable, which allows analysis of the biofilm with 
conventional microbiological methods such as microscopy (including scanning and 
transmission electron microscopy or confocal laser scanning microscopy), staining or viable 
colony counting. One drawback of this approach is that they all require removal of the biofilm 
from its natural environment prior to analysis, which may cause changes in structure and/or 
viability. It is also not possible to monitor the processes of biofilm growth and establishment 
in real time. 
  
Direct, non-invasive methods of monitoring biofilms would, in principle, allow insight into the 
entire process of biofilm development in real-time without interference. Methods have been 
developed based on differential turbidity, heat transfer, bioluminescence, computerized 
image analysis and spectroscopy [27]. However, the challenge lies in correlating changes in 
measured parameters with actual processes in the biofilm. Flemming [28] categorises 
techniques used to monitor biofilms as follows; (i) systems that detect biofilm by deposition 
of material and changes in thickness of layer without differentiating between biotic and 
abiotic components (ii) systems that can distinguish between biotic and abiotic components 
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and (iii) systems that provide detailed information about the chemical composition of the 
microorganisms involved. Janknecht and Melo [27] add a fourth category; that of systems 
that monitor metabolic activity. IMC falls within the latter category (and may also be 
considered as part of the second category as abiotic components would not register any 
metabolic activity). 
 
1.2. Isothermal microcalorimetry for biofilm studies 
Several recent studies report the use of IMC for monitoring biofilm activity suggesting the 
technique has much potential [29]. For instance, Clauss et al [30] monitored biofilms of 
Staphylococcus aureus growing on human and bovine bone grafts, while Astasov-
Frauenhoffer et al [31] investigated variability and dynamics of a triple-species biofilm and 
determined efficacy of amoxicillin and metronidazole combinations against biofilms of 
various species [32]. Said et al [33] determined the efficacy and mechanism of action of an 
anti-biofilm wound dressing. Lerchner et al [34] note, however, that despite the widespread 
use of IMC for studying planktonic cells, its use for biofilm investigation is rarely considered. 
This may be because the data are complex to interpret, but may also be ascribed to 
experimental limitations. IMC experiments are typically conducted in closed ampoules, and 
this arrangement is not particularly suited to the study of biofilms as the limited nutrient 
supply may result in the bacteria entering a stationary phase and/or that metabolic by-
products poison the medium, leading to cell death. It is also necessary to generate the 
biofilm on a coupon as described above prior to calorimetric measurement, so the processes 
of formation and growth are not observed as they occur prior to experimental measurement.  
 
1.3. Flow calorimetry for biofilm studies 
A more effective arrangement would allow fresh medium and/or bacterial culture to be 
circulated from an external reservoir through the calorimetric chamber, keeping nutrient 
levels high. Such systems are known as flow calorimeters, and fall under the category of 
plug flow reactors as defined above. They can be configured to circulate material back to the 
reservoir (continuous-loop) or to flow material to waste. Flow calorimeters have many 
advantages that allow biofilms to form and to remain viable over extended time periods; 
nutrient levels and/or compositions can be optimised, planktonic cells can be continuously 
added, shear forces may exist in the circulating liquid and it is possible to maintain or control 
pH, preventing conditions arising that limit cell growth. From the perspective of interrogating 
biofilms, it is possible to add agents that modify metabolic rates or pathways or which are 
designed to eradicate biofilms. Antimicrobial agents may also be titrated into the bioreactor, 
and so it is easy to get a direct measurement of antimicrobial efficacy, including 
determination of minimum inhibitory and minimum bactericidal concentrations. 
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Despite these advantages, flow calorimetry has not been widely applied to biofilm 
investigation. Lerchner et al [34] discuss a flow calorimeter based on a solid-state (or chip) 
design and use it to study Pseudomonas putida biofilms, although in this case the biofilms 
were cultured prior to calorimetric measurement. Mariana et al [35] used the same chip 
calorimeter to monitor eradication of P. putida biofilms with antibiotics. Morais et al [36] have 
also used chip calorimeters to investigate antimicrobial efficacy of biofilms. Peitzsch et al 
[37] used flow calorimetry to study biofilms of Escherichia coli. Lerchner et al [34] discuss 
some of the potential limitations hindering widespread use of flow calorimetry; the cost of the 
calorimeter can be high, they are not suited to high throughput studies, experiments may 
take days to weeks and it can be difficult to manipulate and investigate substratum effects on 
the biofilm. Additionally, it can be difficult to maintain anaerobic conditions and there is a 
need to minimise the temperature difference between the external reservoir and the 
calorimeter.  
 
Since many commercially available IMC instruments are designed to accept removable 
ampoules, it is possible to consider the development of a system that flows liquid through the 
ampoule from an external reservoir. The ampoule is housed in the calorimeter and so power 
data can be recorded from the medium flowing through it. Constructing a flow system in this 
way involves relatively low cost (assuming the calorimeter itself is already available). Here, 
we outline the design simple flow system developed to fit into a commercial isothermal 
calorimeter. It is constructed so that different materials can be connected to the flow lines 
within the ampoule itself. In this way, the system may be used to investigate biofilm 
formation on a wide range of materials used for medical tubing. It would be equally be 
feasible to load the ampoule with pelletised samples so test biofilm formation on any material 
used for fabricating medical devices and implants. We demonstrate application of the flow 
system to biofilm formation on the internal walls of silicone tubing.  
 
2. Material and methods 
All experiments were conducted in a 2277 Thermal Activity Monitor (TAM, TA Instruments 
LLC). The instrument utilises removable ampoules, which means it is relatively easy to 
design and construct specific apparatus to fit in the measuring position. In this case, the flow 
system was constructed to fit into the 20 mL calorimeter. 
 
2.1. Development of the flow reactor 
The objective of the work was to create a plug flow system to facilitate formation and 
maintenance of a biofilm within medical tubing. The simple system designed (shown 
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schematically in Figure 1) comprised an external bioreactor, the contents of which were 
circulated through an ampoule housed within the TAM. The bioreactor was maintained at 37 
oC by a jacketed water bath. Silicone tubing (Tygon® peristaltic pump tubing, I.D. 2.06 mm) 
was used to attach the bioreactor to the ampoule. The ampoule itself was machined from 
stainless steel and was of 20 mL volume. Two stainless steel tubes were set through the lid 
of the ampoule; in use, the tubing being tested (up to 15 cm in length) can be connected to 
the inlet and outlet lines and coiled within the ampoule. The ampoule was filled with sterile 
distilled water (10 mL) to act as a heat-transfer fluid enabling heat exchange with the 
calorimeter. This design maximises versatility of the system because tubing of different 
material can be connected or it is possible simply to fill the ampoule with pellets of a sample. 
A heat exchange coil was incorporated before the inlet tube, and mounted inside the body of 
the calorimeter, to ensure that medium arriving from the bioreactor was at exactly the same 
temperature as the calorimeter. A peristaltic pump (Gilson Minipuls 3) was mounted in the 
outflow line and used to circulate media at 4 mL/h (flow rates suggested not to cause noise 
in the baseline signal of flow calorimeters range from 3.5 mL/h [38] to 100 mL/h [39], so the 
lower end of this range was selected).  
 
All experiments were performed at 37 oC. Data were captured with the dedicated software 
package Digitam 4.1 (1 data point every 10 s, amplifier setting 300 µW). The instrument was 
calibrated periodically by the electrical substitution method (wherein a known current is 
passed through a calibrated resistor mounted at the base of the calorimeter). Data were 
analysed with Origin 8.1 (Microcal Software Inc). 
 
2.2. Biofilm models 
The organism used was Staphylococcus aureus NCIMB 9518. The bacterial culture, 
consisting of tryptone soya broth (TSB, 200 mL, Thermofisher) inoculated with S. aureus to a 
final population density of 1x106 CFU/mL, was maintained in the bioreactor with constant 
stirring and circulated through the calorimetric ampoule at 4 mL/h. Anaerobic conditions 
were maintained by placing a layer of mineral oil on the surface of the contents of the 
bioreactor to minimise rates of gas exchange with the environment. The power signal from 
the calorimeter was used as an indicator of biofilm formation during the experiment. After 
each experiment the catheter tubing was removed and several tests were performed to 
visualise and confirm biofilm formation. 
 
Staining: Crystal violet staining was used to visualise biofilm presence in the tubing following 
calorimetric experimentation [40]. Crystal violet solution (100 µL, Fisher) was pipetted 
through the tubing. The stained section was then thoroughly rinsed with distilled water until 
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the water running off was visibly clear. The same procedure was applied to an equivalent 
length of clean tubing in order to compare the extent of ‘background’ staining.  
 
Colony counting: The presence of viable bacteria in the biofilms was confirmed by viable 
colony counting following the method outlined by Nowatzki et al [24]. The outer surface of 
the catheter section was wiped with 70% ethanol then lengths (2 cm) were cut and rinsed 
gently with phosphate buffered saline (PBS, Thermofisher) to remove any non-adherent 
cells. The pieces were then transferred to bijous containing PBS (5 mL). The samples were 
subjected to three cycles of vortexing for one minute followed by sonication for five minutes. 
Colony counts were determined by serially diluting the PBS from the ampoules and spread 
plating onto iso-sensitest agar (Thermofisher). Colonies were counted following 16h 
incubation at 37 oC. Counts are expressed as CFU/cm2 of inner tubing surface.  
 
Imaging: Scanning electron microscopy (SEM) was used to image biofilm formation on 
silicone tubing walls. Lengths of tubing (2 cm) were cut and gently rinsed in saline to remove 
planktonic cells. The tubing was then placed into 2.5% glutaraldehyde solution overnight 
before soaking in successive concentrations of ethanol (10%, 25%, 50%, 70%, 90% and 
100%). Tubing was kept in each concentration of ethanol for 10 minutes. Samples of tubing 
were then dehydrated in alcohol and air dried before being adhered onto an SEM stub with 
carbon discs (both Agar Scientific, UK). Prepared samples were then coated with gold 
(10nm) in a Quorum Q150T Sputter coater (Quorum Technologies, UK), then transferred to 
the FEI Quanta 200F (Eindhoven, The Netherlands) SEM for imaging. 
 
Antimicrobial challenge: Further confirmation of biofilm presence and activity during 
calorimetric measurement was achieved by challenge with silver nitrate (AgNO3) solution 
[34, 40]. Biofilms that had been established in the tubing in the calorimeter were thoroughly 
rinsed in situ by flowing sterile distilled water (200 mL) at the fastest rate achievable by the 
pump (2 mL/min). The external bioreactor was then removed, cleaned and autoclaved 
before being charged with fresh TSB/AgNO3 solution (1x10-4M). The AgNO3 solution was 
circulated over the biofilm at 4 mL/h.  
 
3. Results and discussion 
The first aim in developing the flow microcalorimeter system was to achieve a stable 
baseline power signal when sterile medium was being circulated, and this was achieved with 
a flow rate of 4 mL/h (Figure 2). There is some fluctuation in the signal, most probably due to 
small changes in room temperature during the measurement period. These fluctuations were 
minimised by incorporating the heat-exchange coil in the inlet line of the system. A 
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significant advantage of the design is that it can be removed from the calorimeter itself, 
allowing sterilisation of the ampoule. 
 
Loading the bioreactor with S. aureus culture resulted in an exothermic peak after a lag 
period of ca. 5h, which increased to reach a plateau after ca. 12 h, Figure 2. It has been 
established that growth of planktonic S. aureus cells in a closed ampoule results in an 
exothermic power that rapidly reduces to a zero power once nutrients in the medium are 
exhausted and/or the metabolites produced by the bacteria have poisoned the medium [41]. 
The data recorded here reach a plateau, meaning the system is undergoing a zero-order 
kinetic process; in other words, there must be on-going metabolic activity within the 
calorimetric ampoule, from biofilm activity. Bacteria existing in a biofilm colony are not 
exponentially increasing in number and are shielded from toxic metabolites but since fresh 
medium is constantly being circulated over the biofilm the bacteria have a nutrient source to 
sustain metabolic activity. 
 
To confirm that the power output was from sessile, surface-attached cells and not because 
of other factors, such as increased friction due to biomass or simply the activity of planktonic 
cells, the silicone tubing was rinsed extensively by flowing 200 mL of sterile distilled water at 
the maximum flow rate achievable with the peristaltic pump. Fresh TSB, dosed with 1x10-4 M 
silver nitrate solution was then introduced into the bioreactor and circulated through the 
calorimeter at 4 mL/h. Said et al [33] have shown previously that silver nitrate solution at this 
concentration is bactericidal against planktonic S. aureus, but has no bactericidal effect 
against an established biofilm. The resulting power data are shown in Figure 3. It is apparent 
that after a small initial disturbance, the power output rapidly returned to that of the steady 
state achieved initially and that the silver nitrate exerted no effect, supporting the hypothesis 
that a biofilm had been established with constant metabolic activity. 
 
In a final calorimetric experiment, TSB was replaced with sterile PBS and circulated through 
the established biofilm. Since PBS contains nothing of nutritional value to the cells, 
metabolic activity quickly reduced to zero, Figure 4. 
 
Following calorimetric experimentation, the silicone tubing was removed from the ampoule 
and analysed. Staining with crystal violet showed clear evidence of cell attachment to the 
tubing, Figure 5. SEM images of the tubing showed clear attachment of cells to the inner 
walls, Figure 6. Viable cell counts from of a section (2 cm) of tubing were 3 x 109 CFU/cm2, 
which corresponds to approximately 3 x 1010 CFU for the total length of tubing, assuming 
uniform cell coverage. The inner volume of the catheter was approximately 1 mL, which 
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implies a cell density of 3 x 1010 CFU/mL. If these cells were in a highly metabolically active 
planktonic state a much higher power would be expected, further supporting the notion that a 
biofilm had formed. 
 
4. Summary 
Isothermal microcalorimetry has much potential for the study of biofilms, but its use is 
frequently restricted to monitoring activity of established biofilms because it is difficult to 
grow and maintain biofilms in closed ampoules. Use of a flow system offers the opportunity 
to provide a continuous supply of nutrients from an external reservoir and so to conduct 
experiments over longer time periods. This permits formation of the biofilm within the 
ampoule and so monitoring of the power changes directly, in real time. The flow system 
reported here is versatile, so easily adapted to study a range of materials, and removable, so 
easy to sterilise. Flowing an S. aureus culture through the system resulted in an increasing 
exothermic power, reaching a plateau after ca. 12 h. It was established that the bacteria 
were in biofilm colony at this stage and that they showed increased resistance to 
antibacterial agents. The flow system can thus be used to establish and monitor biofilm 
formation and growth on a range of medical-grade plastics. 
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Figure 1. Schematic representation of the flow calorimeter 
Figure 2. Power-time data for the control (TSB) and for a suspension of S. aureus  
Figure 3. Power-time data for showing formation of the biofilm (black) and the 
response of an established biofilm to exposure to AgNO3 (1 x 10-4 M, Grey) 
Figure 4. Power-time data showing the response of an established biofilm to a 
nutrient-poor medium (PBS) 
Figure 5. Sections of silicone tubing after staining with crystal violet solution. Left; 
tubing exposed to S. aureus suspension. Right; Control tubing exposed to TSB only 
Figure 6. SEM image of a cross-section of tubing exposed to S. aureus suspension, 
showing clear evidence of biofilm formation. 
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